ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,150, issued on March 31, was assigned to MABWELL (SHANGHAI) BIOSCIENCE Co. LTD. (Shanghai).
"Antibody against Nectin-4 and application thereof" was invented by Hongyuan Ren (Shanghai), Jian Zhu (Shanghai), Jian Lin (Shanghai), Lichun Wang (Shanghai), Xiaohong Xu (Shanghai), Xiaofang Deng (Shanghai), Jianjun Bi (Shanghai), Jin Wang (Shanghai) and Jian Wu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an antibody molecule that binds to human Nectin-4 or a fragment thereof. The antibody is obtained by means of hybridoma screening and humanization techniques, and is used for the prevention or treatment of a cancer, and may be used...